| RS2540100523 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540100653 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540100842 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540100894 |
COL2A1
|
Health Risk |
Pathogenic |
Type 2 collagenopathy, Type 2 collagenopathy |
| RS2540100937 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540102569 |
COL2A1
|
Health Risk |
Likely pathogenic |
COL2A1-related disorder, COL2A1-related disorder |
| RS2540102575 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540102645 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540102657 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540103100 |
LPL
|
Health Risk |
Likely pathogenic |
— |
| RS2540103224 |
LPL
|
Health Risk |
Pathogenic |
— |
| RS2540103296 |
LPL
|
Health Risk |
Likely pathogenic |
Hyperlipidemia, familial combined |
| RS2540104351 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS2540104584 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540104783 |
LPL
|
Health Risk |
Pathogenic |
— |
| RS2540105508 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stickler syndrome type 1, Marfan syndrome |
| RS2540105517 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540105673 |
LPL
|
Health Risk |
Likely pathogenic |
— |
| RS2540105677 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540105684 |
LPL
|
Health Risk |
Likely pathogenic |
— |
| RS2540105806 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540105848 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540105853 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS2540105931 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540106845 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540106999 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540107050 |
LPL
|
Health Risk |
Likely pathogenic |
Hyperlipoproteinemia, type I |
| RS2540107072 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540107104 |
LPL
|
Health Risk |
Pathogenic |
— |
| RS2540107190 |
LPL
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hyperlipoproteinemia |
| RS2540107214 |
LPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hyperlipidemia |
| RS2540107223 |
LPL
|
Health Risk |
Pathogenic |
Hyperlipoproteinemia, type I |
| RS2540107240 |
LPL
|
Health Risk |
Likely pathogenic |
— |
| RS2540107246 |
LPL
|
Health Risk |
Pathogenic |
— |
| RS2540107342 |
LPL
|
Health Risk |
Pathogenic |
Hyperlipoproteinemia, type I |
| RS2540107709 |
COL2A1
|
Health Risk |
Pathogenic |
COL2A1-related disorder, COL2A1-related disorder |
| RS2540107719 |
PAK1
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with macrocephaly, seizures |
| RS2540107727 |
COL2A1
|
Health Risk |
Likely pathogenic |
Spondyloepiphyseal dysplasia, Stanescu type |
| RS2540107776 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540107843 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540107881 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540107941 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540107950 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540108712 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540108803 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540109673 |
LPL
|
Health Risk |
Pathogenic |
Hyperlipidemia, familial combined |
| RS2540110308 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540110405 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
15 conditions, 15 conditions |
| RS2540110816 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540110841 |
SDHAF2
|
Health Risk |
Likely pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary cancer-predisposing syndrome |
| RS2540111345 |
LPL
|
Health Risk |
Pathogenic |
— |
| RS2540111400 |
LPL
|
Health Risk |
Pathogenic |
— |
| RS2540111558 |
LPL
|
Health Risk |
Pathogenic |
— |
| RS2540111594 |
LPL
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2540111730 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome, Stickler syndrome |
| RS2540111777 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540111800 |
COL2A1
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2540111821 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540111973 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540111978 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS2540113039 |
COL2A1
|
Health Risk |
Likely pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS2540113158 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540113244 |
COL2A1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2540113253 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540113591 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540113603 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540113631 |
COL2A1
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia congenita, Spondyloepiphyseal dysplasia congenita |
| RS2540113782 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540113868 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540116264 |
FGFR2
|
Health Risk |
Likely pathogenic |
FGFR2-related disorder, FGFR2-related disorder |
| RS2540116695 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540116704 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540116801 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540119287 |
SCN8A
|
Health Risk |
Likely pathogenic |
Cognitive impairment with or without cerebellar ataxia, Cognitive impairment with or without cerebellar ataxia |
| RS2540119648 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540119682 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540119803 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540119865 |
SCN8A
|
Health Risk |
Likely pathogenic |
Cognitive impairment with or without cerebellar ataxia, Early-infantile DEE |
| RS2540121985 |
COL2A1
|
Health Risk |
Likely pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS2540121990 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540122013 |
ZMYND11
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 30 |
| RS2540122196 |
COL2A1
|
Health Risk |
Likely pathogenic |
COL2A1-related disorder, COL2A1-related disorder |
| RS2540122241 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540122331 |
COL2A1
|
Health Risk |
Likely pathogenic |
Spondyloperipheral dysplasia, Type 2 collagenopathy |
| RS2540122346 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540122419 |
FGFR2
|
Health Risk |
Likely pathogenic |
FGFR2-related craniosynostosis, Inborn genetic diseases |
| RS2540123164 |
ZMYND11
|
Health Risk |
Likely pathogenic |
— |
| RS2540123213 |
ZMYND11
|
Health Risk |
Likely pathogenic |
— |
| RS2540124016 |
SDHAF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2540124080 |
SDHAF2
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS2540124290 |
SDHAF2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2540124377 |
SDHAF2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2540124427 |
SDHAF2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2540124442 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540124552 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540124759 |
SDHAF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS2540124831 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540124855 |
SDHAF2
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary cancer-predisposing syndrome |
| RS2540124889 |
SDHAF2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS2540124926 |
SDHAF2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary pheochromocytoma and paraganglioma |